Medical device manufacturers today face unprecedented challenges in new business development as markets shift toward preventive devices, telemedicine, and medical IoT platforms. Traditional market research methods struggle to capture opportunities in these emerging domains, while regulatory complexity and the transition from product sales to subscription models create additional barriers to growth. We provide comprehensive consulting services that leverage proprietary AI tools and deep industry expertise to support medical device companies through the entire journey from theme exploration to sustainable commercialization, addressing these multifaceted challenges with proven methodologies and hands-on implementation support.
Business Development Challenges Facing Medical Device Manufacturers
Market Transformation Driven by Digital Health and Preventive Devices
The healthcare industry is experiencing a fundamental shift from treatment-focused care to prevention-oriented approaches, creating explosive demand for preventive devices and remote monitoring solutions. This transformation has intensified as AI diagnosis capabilities and medical IoT technologies reshape competitive landscapes, requiring medical device manufacturers to integrate software development and data analytics expertise with traditional device engineering. Theme exploration in these emerging markets presents unique difficulties because conventional research methodologies cannot adequately capture opportunities that don’t yet exist in clearly defined forms.
Medical device companies face particular challenges when attempting to cross the chasm from early adopters to mainstream healthcare providers in telemedicine and home medical care segments. While innovative clinicians may embrace new technologies despite incomplete evidence, the broader market demands proven clinical outcomes, seamless workflow integration, and clear economic value. Successfully navigating this transition requires sophisticated strategies that address not only technical requirements but also market education, reimbursement pathways, and organizational change management across diverse stakeholder groups.
Regulatory Complexity and Extended Time-to-Market Challenges
Balancing innovation speed with regulatory compliance requirements across multiple jurisdictions has become increasingly complex as manufacturers pursue global market opportunities. PoC validation requirements have grown more stringent for AI-enabled and connected devices, where software updates can continuously modify functionality and regulatory authorities demand ongoing monitoring systems. Business plan development becomes particularly challenging when regulatory timelines and reimbursement pathways remain uncertain, forcing difficult decisions about market sequencing and resource allocation.
Medical device manufacturers face resource allocation dilemmas between maintaining core business operations and investing in new business development initiatives with uncertain outcomes. Limited engineering resources, regulatory expertise, and management attention must be carefully distributed across competing priorities, requiring sophisticated planning that accounts for extended development cycles and evolving compliance requirements.
Business Model Evolution: From Product Sales to Subscription Services
Healthcare providers increasingly demand outcome-based pricing and subscription models rather than traditional capital equipment purchases, reflecting broader industry trends toward value-based care and operational flexibility. This shift creates significant challenges for medical device manufacturers as subscription models defer revenue recognition over contract terms, generating cash flow pressures during transition periods even while promising more predictable long-term revenue streams. Data monetization opportunities through medical IoT platforms offer attractive new revenue sources but require capabilities in data science, software development, and digital service delivery that extend beyond traditional manufacturing competencies.
Establishing recurring revenue streams while maintaining profitability proves difficult because subscription models typically involve lower per-transaction revenue than equipment sales, requiring larger customer bases and new capabilities in customer success management and churn prevention. Organizational resistance to business model transformation represents a significant internal challenge as sales teams, manufacturing operations, and finance departments must adapt to fundamentally different processes and success metrics.
ConnectaBlue’s New Business Development Support for Medical Device Manufacturers
End-to-End Support from Theme Exploration to Commercialization
We provide comprehensive support through the entire journey from market environment analysis to business theme identification using proprietary AI tools, followed by business plan formulation and hands-on implementation guidance. Our process begins with thorough industry trend research and competitive analysis that examines regulatory developments, customer needs, and market dynamics across multiple dimensions to identify opportunities aligned with your organization’s capabilities. This comprehensive analysis provides the foundation for informed theme exploration that considers not just current conditions but also emerging trends and future market potential.
Business plan development transforms validated themes into actionable roadmaps integrating differentiation strategies, market entry approaches, and financial projections that address all aspects of commercialization. We remain actively involved through implementation, providing hands-on business development support for PoC validation, customer development, partnership negotiations, and organizational structure construction. Progress management and PDCA cycle establishment create infrastructure for continuous improvement, ensuring initial plans evolve appropriately as market conditions change and new insights emerge through execution.
AI-Powered Business Theme Exploration Process
Our theme exploration process conducts thousands to tens of thousands of market trend and customer/competitor surveys using AI tools, providing unprecedented research breadth and depth that identifies patterns and opportunities impossible to detect through conventional methods. Comprehensive analysis identifies potential business opportunities in preventive devices, telemedicine, and medical IoT domains by synthesizing information from clinical literature, regulatory developments, competitive landscapes, and emerging technologies. For example, our analysis might reveal how demographic trends, healthcare cost pressures, regulatory changes, and technological advances converge to create specific opportunities in remote patient monitoring or home-based diagnostic solutions.
Detailed verification of marketability, competitiveness, and feasibility for promising themes employs focused research examining target customer segments, competitive offerings, regulatory pathways, reimbursement prospects, and implementation challenges. This rigorous evaluation process often reveals issues that would otherwise emerge only later in development, saving substantial time and resources by filtering out less viable concepts early. Materialization of selected ideas as concrete business models includes defining specific product concepts, value propositions, pricing strategies, distribution approaches, and development timelines that provide clear direction for implementation and investment decisions.
Business Creation Infrastructure Development for Sustainable Innovation
Successful new business development requires organizational infrastructure that systematically generates, evaluates, and commercializes innovations over time rather than pursuing isolated initiatives. We support process design for business creation and formulation of evaluation indicators that establish clear methodologies guiding how your organization identifies opportunities, assesses potential, develops plans, makes investment decisions, and manages implementation. Construction of decision-making mechanisms establishes governance structures balancing senior leadership oversight with team empowerment to move quickly and adapt to market feedback.
Human resource development planning addresses the challenge of building teams with diverse skills necessary for medical device business development, including clinical knowledge, regulatory expertise, technical capabilities, and market understanding. We also propose development of IT, finance, and marketing infrastructure necessary for business expansion, creating comprehensive support systems that enable sustainable growth. Through cultivating organizational culture that nurtures new business seeds through commercialization, we help establish capabilities for ongoing innovation as a core strategic competency rather than occasional activity.
ConnectaBlue’s Approach to Medical Device Industry-Specific Challenges
Accelerating PoC Validation and Crossing the Chasm in Digital Health Markets
We provide structured PoC verification methodologies specifically designed for AI diagnosis and medical IoT solutions, establishing clear validation frameworks that satisfy both clinical requirements and business case development needs. Our customer development strategies leverage proprietary web marketing methods to identify early adopters and understand their specific needs, enabling targeted engagement that accelerates initial market traction. Evidence generation frameworks help medical device companies build the clinical validation and economic justification necessary for mainstream market adoption.
Crossing the chasm in telemedicine and home medical care segments requires understanding adoption patterns unique to these markets, where workflow integration, user experience, and support infrastructure become critical success factors beyond core device functionality. We develop chasm-crossing tactics that address the distinct concerns of mainstream healthcare providers, including integration complexity, staff training requirements, and return on investment demonstration. This approach helps companies transition from successful pilots with enthusiastic early adopters to scalable commercial operations serving the broader market.
Subscription Model Design and Recurring Revenue Strategy
We support business model transformation from capital equipment sales to subscription-based service offerings, helping medical device manufacturers navigate the strategic and operational changes this transition requires. Pricing strategy development for outcome-based contracts and data-enabled services addresses the complex challenge of value quantification in subscription contexts, where pricing must reflect ongoing value delivery rather than one-time product transfer. Financial modeling accounts for transition period cash flow challenges, ensuring companies maintain financial stability while building recurring revenue streams.
Customer success infrastructure design ensures retention and expansion in subscription models by establishing proactive engagement processes, value demonstration mechanisms, and expansion selling approaches. Our business plan development for subscription models integrates all these elements into comprehensive strategies that manage transition risks while capturing long-term revenue opportunities. This holistic approach addresses not just pricing and contracts but also organizational capabilities, technology systems, and customer relationship management processes essential for subscription business success.
Regulatory-Aware Business Planning and Market Entry Strategy
Our business plan development integrates regulatory pathway analysis and timeline projections, ensuring commercialization strategies account for approval requirements and compliance complexities from the outset. Multi-jurisdictional market entry sequencing optimizes the order in which companies pursue different geographic markets based on regulatory complexity, market attractiveness, and strategic fit. This sequenced approach manages resource requirements while building momentum through early market successes that validate the business model and generate revenue supporting subsequent expansions.
Risk mitigation strategies for theme exploration in highly regulated preventive device and AI diagnosis domains help companies pursue innovation while managing uncertainty about regulatory requirements and approval timelines. We develop reimbursement strategy formulation aligned with evolving healthcare payment models, recognizing that regulatory approval alone does not ensure commercial success without adequate coverage and payment. This comprehensive approach to regulatory and reimbursement planning ensures business plans reflect realistic pathways to market access and revenue generation rather than optimistic assumptions that may prove unfounded.
4. Three Distinctive Features of ConnectaBlue’s Medical Device Consulting Services
4.1 Extensive Track Record in Industrial Fields Requiring Advanced Expertise
We excel in new business development support across industrial fields including materials, chemicals, processing technologies, and medical device manufacturing. Our consultants possess deep knowledge of complex technical domains where conventional consulting business approaches often fall short. By combining proprietary AI tools with specialized industry expertise, we conduct large-scale surveys and estimations at unprecedented speed, identifying commercialization themes and market entry scenarios that traditional methods frequently overlook.
Our approach integrates AI-generated insights with consultants’ empirical knowledge and advanced know-how accumulated through numerous client engagements. This combination enables us to develop business strategies that are both innovative and grounded in practical realities. We support theme exploration in emerging areas where standard market research provides limited guidance, helping companies determine optimal development directions with confidence.
4.2 Proprietary AI Tools and Know-How for Comprehensive Theme Exploration
We have developed proprietary AI tools that optimally combine multiple generative AI platforms with different characteristics and strengths. These tools enable comprehensive theme exploration that dramatically expands the scope of opportunity identification compared to conventional approaches. Our AI prompt templates are specifically optimized for new business theme exploration in medical device contexts, incorporating industry-specific terminology, regulatory considerations, and market dynamics.
The capability to conduct tens of thousands of surveys and estimations in short periods represents a fundamental advantage. This large-scale analytical approach uncovers patterns, opportunities, and market gaps that would remain invisible through manual research or limited sampling. By escaping from conventional person-dependent methods such as idea contests and workshops, we enable objective and comprehensive business development that reduces reliance on individual intuition.
Our consulting practice systematically applies these AI capabilities across the entire business development process. From initial market environment analysis through detailed feasibility assessment, AI tools accelerate each phase while maintaining analytical rigor. This technology-enabled approach allows us to explore broader opportunity spaces, evaluate more alternatives, and deliver insights faster than traditional consulting business methodologies.
4.3 Needs Exploration and Customer Development Leveraging Web Marketing Methods
We visualize latent needs in preventive devices and home medical care through proprietary web data analysis that reveals what potential clients are actively seeking. Our methodology extracts authentic user interests from search behavior and browsing patterns, capturing “true feelings” and “signs” that questionnaires and conventional market research cannot detect. This data-driven approach provides objective evidence of market demand rather than relying solely on stated preferences or expert opinions.
By identifying market gaps that existing businesses overlook and demand trends expected to expand in the future, we help clients focus resources on high-potential opportunities. Our web marketing methods enable precise targeting of early adopters and building relationships with potential clients before competitors recognize emerging opportunities. This capability proves particularly valuable in nascent markets where traditional customer identification methods struggle to deliver results.
The scientific derivation of business opportunities with high success probability increases precision of investment decisions and reduces the risk inherent in new business development. We support clients in determining which opportunities warrant investment based on objective data rather than subjective assessments. This evidence-based approach to customer development and needs exploration represents a distinctive advantage in our consulting services.
5. Case Studies: Medical Device Manufacturers’ New Business Success Stories
5.1 Medical Device Manufacturer’s Entry into Preventive Healthcare Field
A medical device manufacturer sought to leverage proprietary technology to expand beyond traditional treatment devices into the prevention market. The company recognized growth opportunities in preventive devices but struggled with theme exploration in an emerging market where conventional research methods provided limited guidance. Uncertainty about market receptivity, optimal business models, and commercialization pathways created hesitation about committing significant resources to development.
We conducted comprehensive theme exploration using AI tools to identify specific preventive device opportunities aligned with the company’s technical capabilities. Following opportunity identification, we supported PoC validation with carefully selected early adopters and developed a detailed business plan incorporating subscription-based pricing models. Our support extended through commercialization, including customer development strategies and organizational structure recommendations for the new business unit.
The initiative achieved successful market entry with a subscription-based remote monitoring service that generated early profitability within the planned timeframe. The company successfully crossed the chasm to mainstream adoption, establishing a new business pillar that diversified revenue streams. This success demonstrated the value of systematic theme exploration and disciplined execution in emerging healthcare markets.
5.2 Pharmaceutical Manufacturer’s Peripheral Business Development
A pharmaceutical manufacturer aimed to diversify revenue streams by developing medical device business leveraging drug discovery technology and knowledge. The company possessed relevant technical expertise but lacked understanding of medical device market dynamics, regulatory pathways, and commercialization strategies. Determining which opportunities to pursue among numerous possibilities presented a significant challenge.
We provided comprehensive support from market research in medical IoT and AI diagnosis domains through commercialization strategy formulation. Our analysis identified specific applications where the company’s pharmaceutical knowledge created competitive advantages. We developed a business plan that addressed regulatory requirements, reimbursement strategy, and partnership approaches for market access.
The company established a new business pillar with differentiated positioning in the medical device market. By successfully navigating regulatory requirements and building a sustainable growth trajectory, the initiative created a meaningful diversification of the company’s portfolio. The new business now contributes significantly to overall company growth and profitability.
5.3 Precision Equipment Manufacturer’s IoT Solution Business Launch
A precision equipment manufacturer sought to transition from capital equipment sales to subscription-based service models using measurement technology. The company recognized that customers increasingly preferred ongoing service relationships over large capital purchases but struggled to design viable subscription offerings. Concerns about revenue recognition patterns, customer acquisition approaches, and organizational transformation created implementation barriers.
We provided business model transformation support including subscription pricing strategy development, customer development methodologies, and organizational structure recommendations. Our financial modeling addressed transition period cash flow challenges and established realistic performance expectations. We also supported the creation of customer success infrastructure essential for subscription model viability.
The company successfully launched an IoT solution business leveraging sensing technology, establishing recurring revenue streams that improved financial predictability. The subscription model expanded customer touchpoints and created opportunities for ongoing value delivery. Applications in telemedicine contexts demonstrated the versatility of the company’s technology platform and opened pathways for continued expansion.
6. About ConnectaBlue: Consulting Firm Delivering Unique Results Through Exceptional Capabilities
6.1 ConnectaBlue’s Organizational Capabilities and Global Network
We are a consulting firm that delivers unique results and experiential value through exceptional individual capabilities and proprietary data and approaches. Comprised of professionals from top consulting firms, we maintain a global network of over 500 consultants enabling comprehensive support across all industries and themes. Our organizational structure emphasizes individual consultant excellence while providing collaborative resources that enhance service delivery.
We serve clients ranging from companies with sales of 10 billion yen to those exceeding 1 trillion yen across diverse industries. Our focus on BtoB contexts enables deep understanding of complex business relationships, long sales cycles, and technical decision-making processes. Clients consistently recognize our ability to provide speedier and higher quality services compared to larger consulting business organizations.
6.2 Specialized Expertise in New Business Development and Industrial Sectors
We have established an overwhelming track record in BtoB marketing, new business development, and R&D support within the consulting industry. Our expertise in industrial fields including materials, chemicals, processing technologies, and medical devices distinguishes us from generalist consulting firms. This specialized knowledge enables us to understand technical complexities, regulatory requirements, and market dynamics that shape business development in these sectors.
AI tools and digital marketing methodologies accelerate client business growth by expanding analytical capabilities and enabling data-driven decision-making. We continuously invest in developing proprietary approaches that create competitive advantages for clients. Our consultants combine technological capabilities with deep industry knowledge and practical implementation experience, ensuring that strategies are both innovative and executable.
6.3 ConnectaBlue’s New Business Development Services
Our new business development services encompass business theme exploration, business plan formulation, hands-on business development support, and business creation infrastructure development. We support companies aiming to launch new businesses or innovate existing operations through consistent processes from market environment analysis to sustainable commercialization. Our approach integrates proprietary AI tools, specialized industry expertise, and proven methodologies tailored to client-specific needs.
For medical device manufacturers, we provide specialized support addressing industry-specific challenges including regulatory complexity, extended development timelines, and evolving business models. Our services help companies identify high-potential opportunities, develop compelling business plans, execute effective commercialization strategies, and build organizational capabilities for sustained innovation. We remain engaged as partners throughout implementation, providing practical guidance that enables clients to achieve their new business objectives and create lasting value.
FAQ
What is new business consulting for medical device manufacturers?
Our new business consulting for medical device manufacturers focuses on practical business development support, from refining a business plan to clarifying a target market and preparing for regulatory and clinical demands. We provide gentle, step‑by‑step guidance tailored to your specific needs and constraints as you explore new business opportunities and manage risks and costs.
How is your consulting business different from general strategy firms?
We are a consulting business dedicated to the medical device field, so we understand clinical workflows, reimbursement, and quality requirements. While strategy firms may charge 20 million yen/month or more, and comprehensive firms around 10 million yen/month, we structure support so medical device companies can access practical, implementation‑oriented advice with clear scope and transparent communication.
What kinds of business development challenges can you support?
We support business development when you are launching a new business, repositioning existing products, or entering unfamiliar markets. Our team helps determine realistic revenue goals, clarify a target market, prioritize projects, and align internal departments so your organization can move forward without overburdening employees or compromising ongoing operations and quality.
What services are typically included in your new business support?
Typical services include opportunity assessment, market and competitor research, business plan creation, go‑to‑market and sales strategy design, and support for implementing pilot projects. We also help create internal decision criteria, coordinate cross‑department communication, and build systems to manage risk, quality, and compliance in parallel with commercial growth activities.
How do you help medical device companies create a realistic business plan?
We work with your team to create a business plan grounded in regulatory timelines, clinical evidence needs, and reimbursement pathways. Together we clarify assumptions about price, volume, and revenue, then map development, marketing, and sales milestones. This process balances ambition with constraints on money, people, and time, supporting long term viability and steady growth.
How do you support market research and target market definition?
We combine desk research, interviews, and field insights to clarify your target market, from hospital segments to specific clinical departments. We examine care pathways, competing technologies, and purchasing processes, then translate findings into practical segmentation, positioning, and pricing hypotheses. This helps you focus efforts where clinical needs, budgets, and decision makers align.
Can you help improve sales approaches for new medical devices?
Yes, we support development of sales narratives that resonate with physicians, nurses, and administrators. We help clarify clinical benefits, economic value, and risk reduction, then organize materials and processes that sales teams can use consistently. Our approach respects existing practices in your organization while gently introducing new, evidence‑based ways to engage customers and partners.
How do you assist with implementing a new business development strategy?
Implementing strategy can be stressful, so we work side‑by‑side with your team to translate plans into concrete tasks, schedules, and ownership. We support coordination across R&D, quality, regulatory, and commercial departments, monitor risks, and adjust plans based on early feedback. The aim is stable execution that protects patient safety while enabling sustainable growth and learning.
What expertise do your consultants have in the medical device industry?
Our consultants bring expertise from device manufacturers, hospitals, and related health technology firms. They understand quality systems, clinical workflows, reimbursement structures, and global regulatory trends. This expertise allows us to bridge gaps between technical development, clinical adoption, and commercial realities, so your teams feel understood and receive practical, context‑aware guidance.
How do you support entrepreneurs starting a new medical device business?
For medical device entrepreneurs, we provide gentle, stepwise support from concept validation to early commercialization. This includes framing a clear problem statement, validating unmet needs with clinicians, building an evidence‑based roadmap, and structuring early partnerships. We aim to reduce uncertainty and emotional burden while protecting long term options for growth and collaboration.
What is the typical process from first contact to project start?
After an initial conversation to understand your concerns, we usually hold a more detailed discussion with key members of your organization. Based on that, we propose a phased project structure, clarifying objectives, scope, expected outputs, and a realistic timeline. Only once you are comfortable with the contents and internal alignment is in place do we move toward a formal contract.
How are consulting fees structured for new business projects?
Fees depend on scope and complexity. As a reference, strategy firms often start from 20 million yen/month, comprehensive firms around 10 million yen/month, and mid‑sized firms from 4 million yen/month. We explain what is included, clarify responsibilities on both sides, and adjust the pace and depth of involvement to match your internal resources and budget situation.
How do you work with internal teams and existing employees?
We respect the experience and workload of your employees and aim to support them, not burden them. Workshops and interviews are conducted with sensitivity to time and psychological safety. We also help clarify roles and communication lines so teams can manage new tasks more comfortably while maintaining their core responsibilities in development, quality, and manufacturing.
Can you support global market entry for medical device companies?
Yes, we support companies considering expansion outside their home market. This can include assessing regulatory and reimbursement differences, understanding local care pathways, and prioritizing countries based on feasibility and risk. We work carefully with your team to determine where new business development efforts are likely to bring sustainable revenue and manageable complexity.
How long do new business consulting projects usually last?
Project duration depends on goals and stage. Early opportunity assessments may run for a few months, while broader strategy and implementation support can extend over a longer term period that covers multiple milestones. We discuss your situation and internal capacity in advance so the schedule feels realistic and does not place unnecessary strain on your organization.
Do you also help with risk management and insurance considerations?
New business initiatives in medical devices always involve risk, so we help you identify clinical, regulatory, and operational risks early. When relevant, we also discuss how insurance, contracts, and quality systems can be aligned with new offerings. The aim is to prevent unpleasant surprises and to support management decisions that balance opportunity with patient safety and compliance.
How do you ensure knowledge transfer to our internal organization?
We prioritize co‑creation and transparency so that knowledge remains in your organization after a project ends. Workshops, templates, and shared documentation are used instead of opaque deliverables. We also encourage cross‑department participation in key discussions, so capabilities in research, development, and marketing accumulate inside your company and support future initiatives.
Can your consultants support both large companies and startups?
We work with a wide range of companies, from large global manufacturers to early‑stage startups. While the scale differs, many concerns—such as clarifying value for clinicians and patients, planning feasible development paths, and coordinating departments—are similar. We adapt our approach so the pace, formality, and tools match your size, culture, and current pressures.
What kinds of internal data or resources do we need to prepare?
In the early phase, basic information about your products, pipeline, organization, and existing markets is usually sufficient. As we progress, we may ask for more detailed data on sales, margins, or clinical performance. We handle sensitive information carefully, and we clarify in advance what is truly essential so your teams are not overwhelmed by data preparation.
How do you support communication with clinical partners and customers?
When appropriate, we help plan how to approach hospitals, clinicians, and other stakeholders, always respecting existing relationships. This can include preparing interview guides, value messages, and materials. We pay close attention to the concerns of busy healthcare professionals so that interactions feel respectful, transparent, and focused on real clinical and operational needs.
Can you assist in prioritizing among multiple new business ideas?
Many organizations have more ideas than capacity. We help you compare options using clear criteria such as clinical need, regulatory difficulty, internal capabilities, cost, and time to revenue. Through structured discussions, we support management in making decisions that feel both rational and emotionally acceptable to stakeholders who have invested effort in earlier concepts.
How do you support management in monitoring progress of new business initiatives?
We help management define practical indicators that reflect learning and risk reduction, not only immediate revenue. Dashboards and review cycles are designed so leaders can grasp progress quickly and intervene when necessary. This provides a calmer environment for teams and makes it easier to adjust plans before issues become costly, while keeping attention on patient impact.
Are you able to advise on digital and data‑driven medical device businesses?
Yes, we also support companies working with digital health, software as a medical device, and data‑driven solutions. For these areas, we focus on interoperability, cybersecurity, and evidence generation strategies, as well as business models suited to recurring revenue. Our aim is to balance technology ambition with regulatory requirements and real‑world workflow integration.
How do you handle confidentiality and sensitive information?
We understand that clinical data, product roadmaps, and partnership discussions are highly sensitive. We sign appropriate confidentiality agreements and limit access within our team to those directly involved. Throughout the project, we confirm with you what can be shared and with whom, so that your intellectual property and competitive position are carefully protected.
Can you support internal education related to business development?
If desired, we can provide internal sessions on fundamentals of business development in the medical device field, tailored to engineers, researchers, or clinical liaisons. These are designed to be gentle introductions that respect existing expertise while helping teams understand how their work connects to market needs, patient outcomes, and the company’s broader strategy.
What happens after a consulting project is completed?
At the end of a project, we summarize key decisions, remaining risks, and next steps in a form that your teams can continue to use. Some clients request periodic follow‑up to review progress or adjust assumptions. Our goal is that you feel equipped to move forward independently, with clarity about priorities, responsibilities, and realistic paths toward sustainable growth.
Do you provide support for internal alignment across departments?
Yes, many difficulties in new business initiatives come from misalignment between development, regulatory, quality, and commercial departments. We facilitate conversations that surface concerns in a respectful way, and we help clarify roles, decision processes, and timelines. This supports smoother collaboration, reduces rework, and creates a more stable environment for teams.
How do you support companies facing resource constraints for new business?
Resource constraints are common, especially when core products must be maintained. We help you realistically assess available people, budget, and time, then design a stepwise roadmap that fits those limits. By clarifying what not to do for now and defining small, validated milestones, we reduce pressure on teams while still moving steadily toward your long term objectives.
Is support available for evaluating potential partnerships or alliances?
We can assist in evaluating potential partners such as distributors, technology providers, or clinical institutions. This may include assessing strategic fit, governance implications, shared risks, and how roles and responsibilities will be divided. We aim to ensure that any partnership supports your new business goals without creating unmanageable dependencies or conflicts.
Do you also support revisions to an existing new business strategy?
Sometimes the environment changes after a strategy is set. We can review your existing new business plans in light of updated clinical evidence, regulatory shifts, or market conditions. Together with your teams, we identify what remains valid, what needs to change, and how to communicate adjustments internally so that employees understand the reasons and feel respected.
How can we explore whether your new business consulting is right for us?
If you are unsure whether our style of new business consulting fits your situation, an initial conversation about your concerns, constraints, and expectations is usually helpful. Based on that, we can outline possible forms of support, and you can consider calmly whether this aligns with your culture, risk tolerance, and the stage of your medical device initiatives.
Are you able to support very early‑stage concept validation?
Yes, we can support very early stages where clinical needs, technical feasibility, and business models are still unclear. We help frame core assumptions, design lean validation steps, and interpret early signals. The goal is not to rush decisions but to reduce uncertainty gradually, so you can determine whether to proceed, pause, or redirect your new business efforts with confidence.
How do you support communication with external investors or boards?
When appropriate, we help structure materials and narratives so that boards or external investors can understand your new business initiatives, associated risks, and planned mitigations. We pay attention to both quantitative and qualitative aspects, supporting management in explaining complex device‑related issues in a calm, transparent way that encourages informed discussion.
Do you work only on large projects or also on smaller advisory engagements?
We support both larger, structured projects and more focused advisory work, depending on your needs and internal constraints. Some organizations prefer a concentrated project with clear milestones, while others benefit from periodic discussions over time. In each case, we aim to provide calm, empathetic support that respects your context and the realities of medical device development.
Can you help align technical roadmaps with commercial priorities?
Yes, we often support alignment between technical roadmaps and commercial priorities. By looking at clinical needs, regulatory pathways, and market timing together, we help teams find a realistic sequence of features and indications. This reduces frustration for engineers and commercial staff, and supports a clearer connection between R&D investments and future revenue.
Do you provide any written tools or templates during projects?
During projects, we frequently provide simple tools and templates for opportunity assessment, risk mapping, and roadmap planning. These are adapted to your terminology and workflow so they can be maintained internally. Our intention is that, over time, your teams feel comfortable using and evolving these tools independently as new business initiatives emerge in your organization.
How do you ensure that clinical value remains central in business discussions?
In medical devices, business success and clinical value are closely connected. We continuously reconnect discussions about revenue, markets, and competition to patient outcomes and safety. By keeping clinicians’ perspectives visible and respecting ethical boundaries, we help ensure that new business initiatives are not only financially viable but also meaningful for healthcare delivery.
Can you briefly explain how buzzwords like bizdev consulting relate to your services?
Some people describe what we do as bizdev consulting or support for an own consulting business in health technology. In practice, our consulting practice focuses on careful client engagements, building relationships with potential clients and partners, and helping independent consultant specialists and entrepreneurs structure long term, sustainable, and ethically grounded projects.
Do you also advise on outreach tools like email campaigns or a linkedin profile?
For some clients, we discuss how thoughtful, modest email campaigns or a clear linkedin profile can support building relationships with clinicians and other stakeholders. Rather than chasing higher fees or aggressive sales, we emphasize respectful communication that reflects your expertise, protects trust, and fits the cautious, evidence‑driven culture of the medical device field.
Can you help with practical topics such as hiring, insurance, or handling money?
Occasionally, especially with smaller firms or entrepreneurs, questions arise around hiring roles for business development, appropriate insurance coverage, or how to allocate money between development and commercialization. We do not sell financial products, but we share structured perspectives so you can discuss options with your own advisors and feel more confident in decisions.
Is your team also passionate about the medical device field itself?
Yes, many of us came from the medical device and healthcare space and remain passionate about supporting safe, effective technologies that genuinely help patients and care teams. This attitude shapes how we design projects, the care we take with data, and the respect we show to everyone involved, from engineers and clinicians to patients and their families.